UP FSDA orders statewide verification of wholesale drug licences

As per the directive, inspection teams will verify whether licensed firms are operating from approved premises and if adequate drug storage facilities are available. Officials will also check the presence of a competent person and verify their experience certificates.

The Uttar Pradesh Food Safety and Drug Administration (FSDA) has ordered a statewide physical verification of all licensed wholesale drug establishments and warehouses following a recent crackdown that detected bogus and non-functional firms, some allegedly linked to the misuse of codeine-based cough syrups and narcotic medicines, officials said.

FSDA Commissioner Roshan Jacob has instructed all assistant commissioners (drugs) and drug inspectors to begin the verification drive across the state from February 2026. The move follows a two-month enforcement drive during which authorities found that several licensed firms were not operating from their registered addresses.

“The decision follows enforcement drives during which it was found that several licensed firms were non-existent at their registered locations,” Roshan Jacob said.

As per the directive, inspection teams will verify whether licensed firms are operating from approved premises and if adequate drug storage facilities are available. Officials will also check the presence of a competent person and verify their experience certificates.

The teams will further examine whether drugs are being stored at locations other than licensed premises and, if so, whether a separate warehouse licence has been obtained.

The FSDA has also permitted wholesale drug licensees to voluntarily surrender their licences before the verification drive begins. Such applications will be accepted and processed for cancellation at the competent level.

In addition, drug inspectors have been directed to issue district-level public advisories, asking building owners to independently verify whether tenants running wholesale drug businesses on their premises hold valid licences.

Roshan Jacob said she has instructed all field officers to ensure strict compliance with the directions, adding that violations will invite action under the Drugs and Cosmetics Act.

Source: Hindustan Times

Related Posts

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’